Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Metabolic disorders, including obesity and type 2 diabetes (T2D), are primary drivers of cardiovascular diseases (CVD).
• Understanding the molecular underpinnings of obesity and T2D is crucial for identifying new therapeutic strategies.
• MicroRNAs (miRNAs), a class of non-coding RNAs, are increasingly recognized as critical regulators of metabolic homeostasis.

Purpose of the Study:

• To review the association between miRNA expression levels and major cardiovascular risk factors.
• To elucidate the molecular mechanisms of the interplay between obesity and T2D, focusing on miRNA-mediated inter-organ crosstalk.
• To discuss the potential role of miRNAs in regulating protective mechanisms, such as antioxidant defense systems.

Main Methods:

• Literature review of studies investigating miRNA expression in metabolic disorders and cardiovascular diseases.
• Analysis of current research on miRNA's role in inter-organ communication (adipose tissue, liver, skeletal muscle).
• Exploration of the link between miRNAs, metabolic risk factors, and cardiovascular events.

Main Results:

• Evidence suggests a strong correlation between altered miRNA expression and the development of obesity, T2D, and CVD.
• miRNAs play a significant role in mediating paracrine signaling between key metabolic organs.
• Specific miRNAs are linked to prominent cardiovascular risk factors and may influence antioxidant defenses.

Conclusions:

• MicroRNAs are pivotal in the complex molecular pathways connecting metabolic disorders and cardiovascular diseases.
• Targeting miRNAs presents a promising avenue for novel therapeutic interventions for metabolic and cardiovascular conditions.
• Further research into miRNA-regulated protective mechanisms could reveal new strategies for disease prevention and treatment.